从Serratia marcescens SP6中优化Serratiopeptidase生产,使用实验设计的顺序策略
Sejal Kumar1, Sourav Bhattacharya2
1Department of Microbiology and Botany, School of Sciences, JAIN (Deemed-to-be University), 34, 1st Cross, J.C. Road, Bangalore, Karnataka, 560027, India.
Current microbiology
|July 8, 2025
概括
这项研究优化了Serratia marcescens SP6发酵,以增加酸酶的产生. 优化条件产生了2495个单位/毫升,增加了10.16倍,使得可持续的酶制造成为可能.
科学领域:
- 生物技术是生物技术.
- 酶工程是什么? 酶工程是什么?
- 微生物发酵 微生物发酵
背景情况:
- 酸酶是一种有价值的酶,具有纤维溶解和抗炎性质.
- 对治疗应用的高需求需要高效和可扩展的生产方法.
- 目前的生产方法需要优化以获得更高的产量.
研究的目的:
- 为了最大限度地利用来自Serratia marcescens SP6.6的酸酶合成.
- 使用顺序实验设计策略优化发酵条件.
- 为了实现工业应用的酶生产的显著增加.
主要方法:
- 11个发酵参数的初始选,使用一次因素和Plackett-Burman设计.
- 鉴定出乳糖,素和初始pH值作为关键影响因素.
- 应用响应表面方法 (中央复合可旋转设计) 以进一步优化.
主要成果:
- 乳糖,素和初始pH值被确定为显著参数 (p < 0.0001).
- 优化条件预测了2489.71 U/mL的酸酶活性.
- 实验验证达到2495U/mL,比未优化的水平增加10.16倍.
结论:
- 顺序优化策略有效地增强了酸盐酶的产生.
- 优化的条件 (10 g/L 素,18.40 g/L 乳糖,pH 7) 适合大规模生产.
- 这项研究表明了高产量酸酶制造的可持续方法.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


